SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-30
👔
Viking Therapeutics, Inc.
@VKTX_InsiderForm 4 Filing: Mancini Marianna Sells $609,635.548 of $VKTX
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
Viking Therapeutics, Inc.
Ticker: $VKTX
Transaction Value
$609,635.548
Price/Share: $12.22
transaction date
2026-07-29
Shares: 49,884
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Mancini Marianna, holds the title of Chief Operating Officer at Viking Therapeutics, Inc..
On 2026-07-29, the insider transacted 49,884 shares.The shares were transacted at a weighted average price of $12.22 per share, resulting in a total market-relevant value of $609,635.548.
Executive Summary Summary
Mancini Marianna (Chief Operating Officer) sold $610K of $VKTX
Post-Transaction Position: 422,760 shares
SEC Accession No: 0001193125-26-324446 (CIK: 1838112)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.